Literature DB >> 8704219

Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: immunophenotypic analysis and factors affecting the speed of recovery.

H Kook1, F Goldman, D Padley, R Giller, S Rumelhart, M Holida, N Lee, C Peters, M Comito, D Huling, M Trigg.   

Abstract

We prospectively studied immune reconstitution in 102 children who underwent T-lymphocyte depleted bone marrow transplants using either closely matched unrelated donors or partially matched familial donors by assaying total lymphocyte counts (TLC), T-cell subsets, B cells, and natural killer cells. TLC, CD3+, and CD4+ T-cell counts remained depressed until 2 to 3 years posttransplant, whereas CD8+ T-cell counts normalized by 18 months, resulting in an inverted CD4:CD8 ratio until 12 months posttransplant. Although the percentage of NK cells was elevated early posttransplant, their absolute numbers remained normal. CD20+ B cells were depressed until 12 to 18 months posttransplant. Factors affecting immunophenotypic recovery were analyzed by nonparametric statistics. Younger patients tended to have higher TLC posttransplant. Higher marrow cell doses were not associated with hastened immunophenotypic recovery. Graft-versus-host disease (GVHD) and/or its treatment significantly delayed the immune reconstitution of CD3+, CD4+, and CD20+ cells. The presence of cytomegalovirus was associated with increased CD8+ counts and a decrease in the percentages of CD4+ and CD20+ cells.

Entities:  

Mesh:

Year:  1996        PMID: 8704219

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  19 in total

Review 1.  Post-transplant immune recovery and the implication for infection risk.

Authors:  Michael E Trigg
Journal:  Int J Hematol       Date:  2002-08       Impact factor: 2.490

2.  Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease.

Authors:  Stefanie Sarantopoulos; Kristen E Stevenson; Haesook T Kim; Whitney S Washel; Nazmim S Bhuiya; Corey S Cutler; Edwin P Alyea; Vincent T Ho; Robert J Soiffer; Joseph H Antin; Jerome Ritz
Journal:  Blood       Date:  2010-11-19       Impact factor: 22.113

3.  Stem cell through present and future.

Authors:  Vijay K Sharma; Utpal K Singh; Rajniti Prasad; Sophie Fletcher
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

4.  Reconstruction of the immune system after unrelated or partially matched T-cell-depleted bone marrow transplantation in children: functional analyses of lymphocytes and correlation with immunophenotypic recovery following transplantation.

Authors:  H Kook; F Goldman; R Giller; N Goeken; C Peters; M Comito; S Rumelhart; M Holida; N Lee; M Trigg
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

5.  Robust CD4+ T-cell recovery in adults transplanted with cord blood and no antithymocyte globulin.

Authors:  Ioannis Politikos; Jessica A Lavery; Patrick Hilden; Christina Cho; Taylor Borrill; Molly A Maloy; Sergio A Giralt; Marcel R M van den Brink; Miguel-Angel Perales; Juliet N Barker
Journal:  Blood Adv       Date:  2020-01-14

Review 6.  Bone marrow transplantation using unrelated donors for haematological malignancies.

Authors:  O Ringdén
Journal:  Med Oncol       Date:  1997-03       Impact factor: 3.064

Review 7.  Biology and clinical effects of natural killer cells in allogeneic transplantation.

Authors:  Jonathan E Benjamin; Saar Gill; Robert S Negrin
Journal:  Curr Opin Oncol       Date:  2010-03       Impact factor: 3.645

8.  Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.

Authors:  Nichole R Klatt; Francois Villinger; Pavel Bostik; Shari N Gordon; Lara Pereira; Jessica C Engram; Ann Mayne; Richard M Dunham; Benton Lawson; Sarah J Ratcliffe; Donald L Sodora; James Else; Keith Reimann; Silvija I Staprans; Ashley T Haase; Jacob D Estes; Guido Silvestri; Aftab A Ansari
Journal:  J Clin Invest       Date:  2008-06       Impact factor: 14.808

Review 9.  Reconstitution of the immune system after hematopoietic stem cell transplantation in humans.

Authors:  Jan Storek; Michelle Geddes; Faisal Khan; Bertrand Huard; Claudine Helg; Yves Chalandon; Jakob Passweg; Eddy Roosnek
Journal:  Semin Immunopathol       Date:  2008-10-24       Impact factor: 9.623

Review 10.  Recombinant Antibodies to Arm Cytotoxic Lymphocytes in Cancer Immunotherapy.

Authors:  Joachim Koch; Michael Tesar
Journal:  Transfus Med Hemother       Date:  2017-09-11       Impact factor: 3.747

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.